ADMS - Adamas Pharmaceuticals Stock Trading

Adamas Pharmaceuticals Inc.(NASDAQ: ADMS) stock trading, description, contact, officers and directors.

About Adamas Pharmaceuticals Inc.

Not available

Stock Information

Adamas Pharmaceuticals Inc. Company Name:

ADMS Stock Symbol:

NASDAQ Market:

Get ADMS Alerts

News, Short Squeeze, Breakout and More Instantly...

RECENT ADMS NEWS

ADMS - Adamas announces issuance of new U.S. patent for GOCOVRI in Parkinson's disease - expands coverage with reduction of 'OFF' time and increased 'good ON' time

EMERYVILLE, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has been issued a new patent (no. 10...
ADMS - Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q1 2020 Results - Earnings Call Transcript

Adamas Pharmaceuticals, Inc. (ADMS) Q1 2020 Earnings Conference Call May 07, 2020 05:00 PM ET Company Participants Peter Vozzo - Investor Relations Neil McFarlane - Chief Executive Officer Vijay Shreedhar - Chief Commercial Officer Chris Prentiss - Chief Financial Officer. C...
ADMS - Adamas Pharma EPS beats by $0.23, misses on revenue

Adamas Pharma (NASDAQ: ADMS ): Q1 GAAP EPS of -$0.59 beats by $0.23 . More news on: Adamas Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...